Pacira BioSciences PCRX

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

• SC TO-TOct. 30, 2026, 7:40 a.m. ETView on SEC.gov
• SCHEDULE 13D/AOct. 13, 2026, 5:54 p.m. ETView on SEC.gov
• 4Oct. 9, 2026, 7:07 p.m. ETView on SEC.gov
• 8-KOct. 8, 2026, 9:24 a.m. ETView on SEC.gov

  Entry into a material definitive agreement · Regulation FD disclosure · Financial statements and exhibits

• 4Aug. 18, 2026, 5:21 p.m. ETView on SEC.gov
• SCHEDULE 13GAug. 7, 2026, 10:33 a.m. ETView on SEC.gov
• 10-QAug. 4, 2026, 4:30 p.m. ETView on SEC.gov
• 8-KAug. 4, 2026, 4:03 p.m. ETView on SEC.gov

  Results of operations and financial condition · Financial statements and exhibits